Many of the same names extended their highs on Thursday, but a few new ones joined in as the market rallied. Gilead Sciences (GILD) gained 2.38 to 96.36 in above-average volume, extending its win streak for a fifth straight session. Shares are 6% above a 90.84 three-weeks-tight buy point. Analysts expect the biotech to report a third consecutive quarter of triple-digit profit growth in Q3, as well as a second straight triple-digit sales gain.